Eco R1 Capital, LLC Vincerx Pharma, Inc. Transaction History

Eco R1 Capital, LLC

  • $1.27 Billion
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$22.6 - $31.0 $10.9 Million - $14.9 Million
-480,505 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$12.85 - $19.95 $6.17 Million - $9.59 Million
480,505 New
480,505 $10 Million

Others Institutions Holding VINC

# of Institutions
2
Shares Held
58K
Call Options Held
0
Put Options Held
0
View Full List

About Vincerx Pharma, Inc.

VINC Quotes by TradingView
  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $1.06M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email